EA201500836A1 - Ингибиторы хеликазы-примазы для применения в способе лечения болезни альцгеймера - Google Patents
Ингибиторы хеликазы-примазы для применения в способе лечения болезни альцгеймераInfo
- Publication number
- EA201500836A1 EA201500836A1 EA201500836A EA201500836A EA201500836A1 EA 201500836 A1 EA201500836 A1 EA 201500836A1 EA 201500836 A EA201500836 A EA 201500836A EA 201500836 A EA201500836 A EA 201500836A EA 201500836 A1 EA201500836 A1 EA 201500836A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- disease
- inhibitors
- helicase
- alzheimer
- primases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Biotechnology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13154982 | 2013-02-12 | ||
PCT/EP2014/052743 WO2014124978A2 (fr) | 2013-02-12 | 2014-02-12 | Inhibiteurs de l'hélicase-primase destinés à être utilisés dans une méthode de traitement de la maladie d'alzheimer |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201500836A1 true EA201500836A1 (ru) | 2016-02-29 |
Family
ID=47709982
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201500836A EA201500836A1 (ru) | 2013-02-12 | 2014-02-12 | Ингибиторы хеликазы-примазы для применения в способе лечения болезни альцгеймера |
Country Status (16)
Country | Link |
---|---|
US (1) | US20150374676A1 (fr) |
EP (1) | EP2956134A2 (fr) |
JP (1) | JP2016507546A (fr) |
KR (1) | KR20150119089A (fr) |
CN (1) | CN105101963A (fr) |
AU (1) | AU2014217962A1 (fr) |
BR (1) | BR112015019220A2 (fr) |
CA (1) | CA2898798A1 (fr) |
CL (1) | CL2015002241A1 (fr) |
EA (1) | EA201500836A1 (fr) |
IL (1) | IL240459A0 (fr) |
MX (1) | MX2015010339A (fr) |
PH (1) | PH12015501762A1 (fr) |
SG (1) | SG11201506153TA (fr) |
WO (1) | WO2014124978A2 (fr) |
ZA (1) | ZA201505243B (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11439608B2 (en) | 2017-09-25 | 2022-09-13 | Qun Lu | Roles of modulators of intersectin-CDC42 signaling in Alzheimer's disease |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2573085A1 (fr) | 2011-09-26 | 2013-03-27 | AiCuris GmbH & Co. KG | Monohydrate de mesylate acétamide N-[5-(aminosulfonyl)-4méthyl-1,3-thiazol-2-yl]-N-méthyl-2-[4-(2-pyridinyl)phényl] disposant d'une gamme de distribution de taille de particules spécifiques et portée de surface spécifique |
CN110062755B (zh) * | 2016-11-28 | 2023-08-29 | 艾库里斯有限及两合公司 | 普瑞利韦的游离碱的马来酸盐、其药物制剂、其制造方法及其用于治疗疱疹病毒的用途 |
WO2022108381A1 (fr) | 2020-11-19 | 2022-05-27 | 주식회사 오에이티씨 | Composition pour la prévention ou le traitement d'une maladie neuro-inflammatoire comprenant de la didanosine |
WO2024047508A1 (fr) * | 2022-08-29 | 2024-03-07 | Assembly Biosciences, Inc. | Compositions pharmaceutiques contre le virus de l'herpès |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DOP2000000109A (es) * | 1999-12-23 | 2002-08-30 | Gerald Kleymann | Derivados de tiazolilamida |
DE102005014248A1 (de) * | 2005-03-30 | 2006-10-05 | Aicuris Gmbh & Co. Kg | Pharmazeutische Zubereitung von N-[5-(Aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamid |
US8299059B2 (en) * | 2009-10-30 | 2012-10-30 | Eli Lilly And Company | Crystalline compound and a process for its preparation |
EP2573085A1 (fr) * | 2011-09-26 | 2013-03-27 | AiCuris GmbH & Co. KG | Monohydrate de mesylate acétamide N-[5-(aminosulfonyl)-4méthyl-1,3-thiazol-2-yl]-N-méthyl-2-[4-(2-pyridinyl)phényl] disposant d'une gamme de distribution de taille de particules spécifiques et portée de surface spécifique |
-
2014
- 2014-02-12 MX MX2015010339A patent/MX2015010339A/es unknown
- 2014-02-12 EP EP14703891.3A patent/EP2956134A2/fr not_active Withdrawn
- 2014-02-12 JP JP2015556537A patent/JP2016507546A/ja not_active Withdrawn
- 2014-02-12 WO PCT/EP2014/052743 patent/WO2014124978A2/fr active Application Filing
- 2014-02-12 CN CN201480008550.6A patent/CN105101963A/zh active Pending
- 2014-02-12 BR BR112015019220A patent/BR112015019220A2/pt not_active IP Right Cessation
- 2014-02-12 CA CA2898798A patent/CA2898798A1/fr not_active Abandoned
- 2014-02-12 US US14/767,163 patent/US20150374676A1/en not_active Abandoned
- 2014-02-12 AU AU2014217962A patent/AU2014217962A1/en not_active Abandoned
- 2014-02-12 KR KR1020157024625A patent/KR20150119089A/ko not_active Application Discontinuation
- 2014-02-12 EA EA201500836A patent/EA201500836A1/ru unknown
- 2014-02-12 SG SG11201506153TA patent/SG11201506153TA/en unknown
-
2015
- 2015-07-21 ZA ZA2015/05243A patent/ZA201505243B/en unknown
- 2015-08-09 IL IL240459A patent/IL240459A0/en unknown
- 2015-08-11 PH PH12015501762A patent/PH12015501762A1/en unknown
- 2015-08-11 CL CL2015002241A patent/CL2015002241A1/es unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11439608B2 (en) | 2017-09-25 | 2022-09-13 | Qun Lu | Roles of modulators of intersectin-CDC42 signaling in Alzheimer's disease |
Also Published As
Publication number | Publication date |
---|---|
WO2014124978A4 (fr) | 2014-12-24 |
CA2898798A1 (fr) | 2014-08-21 |
PH12015501762A1 (en) | 2015-11-09 |
BR112015019220A2 (pt) | 2017-07-18 |
WO2014124978A2 (fr) | 2014-08-21 |
EP2956134A2 (fr) | 2015-12-23 |
US20150374676A1 (en) | 2015-12-31 |
JP2016507546A (ja) | 2016-03-10 |
IL240459A0 (en) | 2015-09-24 |
AU2014217962A1 (en) | 2015-09-17 |
MX2015010339A (es) | 2015-11-16 |
CL2015002241A1 (es) | 2016-02-19 |
WO2014124978A3 (fr) | 2014-10-30 |
ZA201505243B (en) | 2017-11-29 |
KR20150119089A (ko) | 2015-10-23 |
CN105101963A (zh) | 2015-11-25 |
SG11201506153TA (en) | 2015-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112018000691A2 (pt) | inibidores peptídicos do receptor de interleucina-23 e seu uso para tratar doenças inflamatórias | |
EA201691354A1 (ru) | Терапевтические ингибирующие соединения | |
EA201500836A1 (ru) | Ингибиторы хеликазы-примазы для применения в способе лечения болезни альцгеймера | |
EA201890308A1 (ru) | Замещенные азасоединения как ингибиторы irak-4 | |
EA201690898A1 (ru) | Способы лечения таупатии | |
EA201890735A1 (ru) | Модуляторы корового белка вируса гепатита b | |
GEP20227369B (en) | Antibodies specific for hyperphosphorylated tau and methods of use thereof | |
EA201690556A1 (ru) | Способы и фармацевтические композиции для лечения вызванных вирусом гепатита в инфекций | |
EA201690969A1 (ru) | Способы и композиции для лечения связанных со старением состояний | |
MY195437A (en) | Methods of Treatment for Cholestatic and Fibrotic Diseases | |
EA201690212A8 (ru) | Способы лечения или профилактики офтальмологических патологических состояний | |
EA201891399A1 (ru) | Бипиразолильные производные, пригодные для лечения аутоиммунных заболеваний | |
EA201500802A1 (ru) | Способы профилактики и/или лечения кардиомиопатии и устранения симптомов кардиомиопатии, фармацевтическая композиция, векторы | |
EA201391582A1 (ru) | Режимы повышения дозы антител против ip-10 | |
CO2017000346A2 (es) | Anticuerpos de unión a protofibrillas aβ | |
EA201792641A1 (ru) | Ингибитор оси igfbp3/tmem219 и диабет | |
BR112019006887A2 (pt) | ativadores do fluxo autofágico e fosfolipase d e depuração de agregado proteico, incluindo tau e tratamento de proteinopatias | |
DK2968470T3 (da) | Modificeret müllersk inhiberende substans (mis)-proteiner og anvendelser deraf til behandlingen af sygdomme | |
EA201792610A1 (ru) | Способ лечения неврологического заболевания | |
EA201691567A1 (ru) | Способы лечения легких травм головного мозга | |
EA201590111A1 (ru) | Моноклональное антитело человека против белка vp1 вируса jc | |
EA201791471A1 (ru) | Способы применения антисмысловых олигонуклеотидов smad7 | |
EA201692402A1 (ru) | Лекарственные формы для местного применения и их использование | |
CL2011003002A1 (es) | Anticuerpo monoclonal o un fragmento del mismo que se une a la proteina m2-1 del virus respiratorio sincicial (vrs) humano; secuencias nucleotidicas; composicion farmaceutica; metodo de diagnostico de infeccion producida por vrs; kit; y uso de dicho anticuerpo para preparar un medicamento. | |
AR108890A1 (es) | Inhibidores de la entrada del cmvh |